Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30189 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Amanda Arand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA.
- Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USA.
- Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis, Indiana, USA.
ORCID-Profile: Amanda Arand, Jennifer A Belsky
Zitieren
APA
Arand, A., Overholt, K., Jacob, S. A., & Belsky, J. A. (2023). Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30189
Vancouver
Arand A, Overholt K, Jacob SA, Belsky JA. Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30189
BibTeX
@article{Arand2023,
author = {Arand, Amanda and Overholt, Kathleen and Jacob, Seethal A and Belsky, Jennifer A},
title = {Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30189}
}
EUVIMED